TipRanks
Advertisement
Advertisement

DWTX Stock Latest News

Dogwood completes patient enrollment in Halneuron trial
The FlyDogwood completes patient enrollment in Halneuron trial
24d ago
DWTX
Dogwood enrolls first 200 patients in HAL-CINP trial
PremiumThe Fly
Dogwood enrolls first 200 patients in HAL-CINP trial
3M ago
DWTX
Dogwood Therapeutics Shareholders Approve Key Governance Measures
PremiumCompany Announcements
Dogwood Therapeutics Shareholders Approve Key Governance Measures
4M ago
8K
DWTX
Dogwood begins Phase 2b extension study for Halneuron
PremiumThe Fly
Dogwood begins Phase 2b extension study for Halneuron
5M ago
DWTX
Dogwood announces commercialization partnership with PRIDCor
PremiumThe Fly
Dogwood announces commercialization partnership with PRIDCor
6M ago
DWTX
Dogwood announces FDA acceptance of SP16 investigational new drug application
PremiumThe FlyDogwood announces FDA acceptance of SP16 investigational new drug application
6M ago
DWTX
DWTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
DWTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago
DWTX
Dogwood Therapeutics Highlights Pipeline Progress and Extended Runway
Premium
Company Announcements
Dogwood Therapeutics Highlights Pipeline Progress and Extended Runway
7M ago
8K
DWTX
Dogwood management to meet with Maxim
PremiumThe Fly
Dogwood management to meet with Maxim
7M ago
DWTX
Dogwood sees cash runway into 4Q26
PremiumThe Fly
Dogwood sees cash runway into 4Q26
7M ago
DWTX
Dogwood reports Q4 EPS (26c) vs. ($6.29) last year
PremiumThe Fly
Dogwood reports Q4 EPS (26c) vs. ($6.29) last year
7M ago
DWTX
Dogwood Therapeutics Shareholders Approve Warrant Exercise Proposal
PremiumCompany Announcements
Dogwood Therapeutics Shareholders Approve Warrant Exercise Proposal
7M ago
8K
DWTX
Dogwood Therapeutics: Strengthened Capital Structure, Advancing Pain Pipeline, and Extended IP Support a Buy-Rated Risk-Reward Profile
PremiumRatingsDogwood Therapeutics: Strengthened Capital Structure, Advancing Pain Pipeline, and Extended IP Support a Buy-Rated Risk-Reward Profile
8M ago
DWTX
Dogwood announces 50% enrollment in ongoing Halneuron Phase 2b trial
Premium
The Fly
Dogwood announces 50% enrollment in ongoing Halneuron Phase 2b trial
8M ago
DWTX
Dogwood Therapeutics outlines 2026 plans for pain pipeline
Premium
Company Announcements
Dogwood Therapeutics outlines 2026 plans for pain pipeline
9M ago
8K
DWTX
Closing Bell Movers: JB Hunt down over 4% after soft Q1 sales
PremiumThe Fly
Closing Bell Movers: JB Hunt down over 4% after soft Q1 sales
9M ago
C
BK
Dogwood files to sell 6.43M shares of common stock for holders
PremiumThe Fly
Dogwood files to sell 6.43M shares of common stock for holders
9M ago
DWTX
Dogwood Therapeutics Raises Capital via Registered Direct Financing
PremiumCompany Announcements
Dogwood Therapeutics Raises Capital via Registered Direct Financing
9M ago
8K
DWTX
Dogwood announces financing of up to $26.8M
PremiumThe Fly
Dogwood announces financing of up to $26.8M
9M ago
DWTX
Dogwood announces interim Phase 2b trial results on Halneuron
PremiumThe FlyDogwood announces interim Phase 2b trial results on Halneuron
10M ago
DWTX
Dogwood files for IP protection for synthetic Halneuron
Premium
The Fly
Dogwood files for IP protection for synthetic Halneuron
10M ago
DWTX
Dogwood Therapeutics Approves Equity Plan Amid Business Merger
Premium
Company Announcements
Dogwood Therapeutics Approves Equity Plan Amid Business Merger
11M ago
8K
DWTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >